| train (N=62) |
test (N=38) |
P-value | |
|---|---|---|---|
| Sex | |||
| female | 4 (6.5%) | 7 (18.4%) | 0.127 |
| male | 58 (93.5%) | 31 (81.6%) | |
| Age (years) | |||
| Mean (SD) | 62.6 (11.3) | 64.6 (8.77) | 0.655 |
| Median [Min, Max] | 63.0 [2.00, 79.0] | 66.5 [33.0, 80.0] | |
| Smoking_history | |||
| No | 17 (27.4%) | 10 (26.3%) | 1 |
| Yes | 39 (62.9%) | 23 (60.5%) | |
| Missing | 6 (9.7%) | 5 (13.2%) | |
| Stage | |||
| IVa | 24 (38.7%) | 10 (26.3%) | 0.293 |
| IVb | 38 (61.3%) | 28 (73.7%) | |
| Treatment_lines | |||
| First_line | 58 (93.5%) | 35 (92.1%) | 1 |
| Second_line | 4 (6.5%) | 3 (7.9%) | |
| Best_response | |||
| PR | 26 (41.9%) | 16 (42.1%) | 0.738 |
| SD | 18 (29.0%) | 11 (28.9%) | |
| PD | 1 (1.6%) | 0 (0%) | |
| Missing | 17 (27.4%) | 11 (28.9%) | |
| clin.benefit | |||
| DCB | 35 (56.5%) | 22 (57.9%) | 0.72 |
| NDB | 21 (33.9%) | 10 (26.3%) | |
| Missing | 6 (9.7%) | 6 (15.8%) |